Literature DB >> 1330419

In vitro activity of CP-74667 compared with four other fluoroquinolones.

R N Jones1, M E Erwin.   

Abstract

CP-74667 is a new, novel C-7 diazabicyclo-fluoroquinolone. Its spectrum of activity includes the Enterobacteriaceae, most nonenteric Gram-negative bacilli, and Gram-positive cocci. Particularly high activity was demonstrated against Xanthomonas maltophilia (MIC50, 1 microgram/ml), Staphylococcus spp. (MIC50s, 0.06-0.12 micrograms/ml) and enterococci (MIC50s, 0.5-4 micrograms/ml). Several staphylococci resistant to ciprofloxacin had potentially susceptible range MICs for CP-74667, for example, less than or equal to 2 micrograms/ml. Fluoroquinolones with this C-7 modification appear promising and worthy of continued pharmaceutical investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330419     DOI: 10.1016/0732-8893(92)90104-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  8 in total

Review 1.  The future of the quinolones.

Authors:  V T Andriole
Journal:  Drugs       Date:  1993       Impact factor: 9.546

2.  Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.

Authors:  V Korten; J F Tomayko; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 3.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 4.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone.

Authors:  B B Gooding; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

6.  In vitro antimicrobial activity of CP-99,219, a new 7-azabicyclonaphthyridone.

Authors:  R N Jones
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.

Authors:  S K Spangler; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 8.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.